Articles of the Month
Videos
Open Access Agreements with Wiley
Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley
Articles
Metabolomics to identify omalizumab responders among children with severe asthma: a prospective study
Carraro, S., di Palmo, E., Licari, A., et al. Allergy. First published: 23 May 2022
RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: evaluating the multiple components of response
Kallieri, M., Zervas, E., Fouka, E., et al. Allergy. First published: 20 May 2022
Epidemiological variations in global burden of atopic dermatitis, an analysis of trends from 1990 to 2019
Peng, C., Yu, N., Ding, Y. and Shi, Y. Allergy. First published: 19 May 2022
Effects of the immunoglobulin/histamine complex in chronic spontaneous urticaria focusing on remission induction
Kim, H.S. and Noh, G. Allergy. First published: 19 May 2022
Innate lymphoid cell subsets in obese asthma patients: Difference in activated cells in peripheral blood and their relationship to disease severity
Sozener, Z.C., Cevhertas, L., Satitsuksanoa, P., et al. Allergy. First published: 18 May 2022
Safety of combining biologics in severe asthma: asthma-related and unrelated combinations
Lommatzsch, M., Suhling, H., Korn, S., et al. Allergy. First published: 18 May 2022
Airway remodelling rather than cellular infiltration characterises both type2 cytokine biomarker-high and -low severe asthma
Khalfaoui, L., Symon, F.A., Couillard, S., et al. Allergy. First published: 17 May 2022
First-in-human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy
Nieto, A., Mazón, Á., Nieto, M., et al. Allergy. First published: 16 May 2022
NTHi infection of pulmonary macrophages drives neutrophilic inflammation in severe asthma
Ackland, J., Barber, C., Heinson, A., et al. Allergy. First published: 16 May 2022
Mollusk allergy: Not simply cross-reactivity with crustacean allergens
Kamath, S.D., Liu, T., Giacomin, P., et al. Allergy. First published: 16 May 2022
Tryptase reference ranges are age-dependent in a large population-based cohort
Slot, M.C., Claessen, L.H.J., Bons, J.A.P., et al. Allergy. First published: 14 May 2022
Comprehending the allergen repertoire of shrimp for precision molecular diagnosis of shrimp allergy
Wai, C.Y.Y., Leung, N.Y.H., Leung, A.S.Y., et al. Allergy. First published: 14 May 2022
Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference
Sousa-Pinto, B., Schünemann, H.J., Sá-Sousa, A., et al. Allergy. First published: 14 May 2022
T cell recovery and evidence of persistent immune activation 12 months after severe COVID-19
Taeschler, P., Adamo, S., Deng, Y., et al. Allergy. First published: 14 May 2022
Long-term effects of homologous and heterologous SARS-CoV-2 vaccination on humoral and cellular immune responses
Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 14 May 2022
Dietary fiber and fermented food consumption and its link to allergic responses
Losol, P. and Barcik, W. et al. Allergy. First published: 12 May 2022
Anti-inflammatory effect of siRNAs targeted il-4 and il-13 in a mouse model of allergic rhinitis
Shilovskiy, I., Nikonova, A., Barvinskaia, E., et al. Allergy. First published: 11 May 2022
Updated threshold dose-distribution data for sesame
Turner, P.J., Gretzinger, M., Patel, N., et al. Allergy. First published: 09 May 2022
Poultry exposure and environmental protection against asthma in rural children
Xing, Y., Wang, M.H., Leung, T.-F., et al. Allergy. First published: 09 May 2022
Similar IgE binding patterns in Gulf of Mexico and Southeast Asian shrimp species in US shrimp allergic patients
Anvari, S., Brunner, S., Tuano, K., et al. Allergy. First published: 07 May 2022
Mouse resident lung eosinophils are dependent on IL-5
Dolitzky, A., Grisaru-Tal, S., Avlas, S., et al. Allergy. First published: 06 May 2022
Comparing the levels of CTLA-4 dependent biological defects in patients with LRBA deficiency and CTLA-4 insufficiency
Catak, M.C., Akcam, B., Bilgic Eltan, S., et al. Allergy. First published: 01 May 2022
The Charcot-Leyden Crystal protein Galectin-10 is not a major determinant of human regulatory T cell function
Arroyo-Hornero, R., Aegerter, H., Hamad, I., et al. Allergy. First published: 01 May 2022
A potential immunological silver bullet for COVID-19: the trivalent chimpanzee adenoviral serotype-68 vector (Tri:ChAd)
Ardicli, O., Azkur, A.K. and Azkur, D. Allergy. First published: 01 May 2022
COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumab
Francis, C.H.R., Hearn, A.P., Ratnakumar, S., et al. Allergy. First published: 01 May 2022
Citations: 1421
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Citations: 409
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Citations: 258
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China
Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752
Citations: 206
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors
Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P. et al. Allergy. 2020; 75: 2828– 2844
Citations: 192
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Citations: 159
Risk factors for severe and critically ill COVID-19 patients: A review
Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455
Citations: 91
Type 2 immunity in the skin and lungs
Akdis, CA, Arkwright, PD, Brüggen, MC, et al. Allergy. 2020; 75: 1582– 1605
Citations: 87
Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2
Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812
Citations: 69
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement
Bousquet, J., Akdis, C.,A., Jutel, M., Bachert, C., Klimek, L., Agache, I. et al. Allergy. 2020; 75: 2440-2444
Citations: 69
Towards a more precise diagnosis of hypersensitivity to beta-lactams — an EAACI position paper
Romano, A, Atanaskovic-Markovic, M, Barbaud, A, et al. Allergy. 2020; 75: 1300– 1315
Citations: 69
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
Gursel, M. and Gursel, I. Allergy. 2020; 75: 1815-1819
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Unexplained recurrent fever: when is autoinflammation the explanation?
Kallinich, T., Gattorno, M., Grattan, C.,E., de Koning, H.,D., Traidl-Hoffmann, C., Feist, E., et al. Allergy. 2013; 68: 285– 296
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19
Bousquet, J., Anto, J.M., Czarlewski, W., Haahtela, T. Fonseca, S.,C., Iaccarino, G. et al. Allergy. 2021; 76: 735– 750
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course
Larenas-Linnemann, D.,E. and Rodríguez-Monroy, F. Allergy. 2021; 76: 910-914
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Asthma and COVID-19: Is asthma a risk factor for severe outcomes?
Johnston, S.,L. Allergy. 2020; 75: 1543-1545
COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumab
Francis, C.H.R., Hearn, A.P., Ratnakumar, S., et al. Allergy. First published: 01 May 2022
Effect of BTN162b2 and Coronavac boosters on humoral and cellular immunity of individuals previously fully vaccinated with Coronavac against SARS-CoV-2: A longitudinal study
Kuloğlu, Z.E., El, R., Guney-Esken, et al. Allergy. First published: 19 April 2022
Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern
Rothen, D.A., Krenger, P.S., Nonic, A., et al. Allergy. First published: 11 April 2022
Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures
Taeschler, P., Cervia, C., Zurbuchen, Y., et al. Allergy. First published: 01 April 2022
Vaccine based on folded RBD-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants
Gattinger, P., Kratzer, B., Tulaeva, I., et al. Allergy. First published: 31 March 2022
Are health care policies for COVID-19 evidence-based?
Bonini, S. and Fiorito, S. Allergy. First published: 30 March 2022
Virus-related stimuli modulate SARS-CoV-2 entry factor expression in pediatric tonsillar epithelial cells in vitro
Hara, M., Morimoto, N., Watabe, T., et al. Allergy. First published: 29 March 2022
Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines?
Eberlein, B., Sonja, M., Fischer, J., Darsow, U., Biedermann, T. and Brockow, K. Allergy. First published: 10 March 2022
Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization
Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022
Has the Spring 2020 lockdown modified the relationship between air pollution and COVID-19 mortality in Europe?
Annesi-Maesano, I., Maesano, C.N., Dessimond, B., et al. Allergy. First published: 25 February 2022
Omicron: A SARS-CoV-2 variant of real concern
Gattinger, P., Tulaeva, I., Borochova, K., et al. Allergy. First published: 21 February 2022
Comparative assessment of allergic reactions to COVID-19 vaccines in Europe and the United States
Hatziantoniou, S., Anastassopoulou, C., Lampropoulou, V., et al. Allergy. First published: 16 February 2022
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses. EAACI task force on eicosanoids consensus report in times of COVID-19
Sokolowska, M., Rovati, G., Diamant, Z., et al. Allergy. First published: 16 February 2022
Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19
Sadlier, C., Albrich, W.C., Neogi, et al. Allergy. First published: 12 February 2022
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals – EAACI recommendations
Jutel, M., Torres, M.J., Palomares, O., et al. Allergy. First published: 11 February 2022
Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination
Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 06 February 2022
Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study
Horn, MP, Jonsdottir, HR, Brigger, D, et al. Allergy. First published: 05 January 2022
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review
Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016
Eczema herpeticum in atopic dermatitis
Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027
CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers
McKenzie, C.I., Varese, N., Aui, P.M., et al. Allergy. 2021; 76: 3028-3040
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study
Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy
Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma
Urbano, A., Plaza, J., Turon, S., et al. Allergy. 2021; 76: 3196-3199
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202
Identification of Ulocladium chartarum as an important indoor allergen source
Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis
Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214
Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
Remington, B.C., Koppelman, S.J., Green, T.D., et al. Allergy. 2021; 76: 3223-3226
Legends of allergy and immunology: Sergio Bonini
Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229
Medical algorithm: Peri-operative management of mastocytosis patients
Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235
Junior Members Corner
Dear Junior Members,
Do not miss the Master Class on Adolescents and Young Adults!
It will take place in person on 20-21 May 2022, in Geneva (Switzerland). The main goal of the Master Class is to understand the challenges faced by adolescents and young adults with allergies and asthma, why adolescents and young adults are at risk patients, and to learn how help adolescents and young adults better self-manage their allergies and asthma. The Master Class will be held by a panel of experts and the organising chairs are Dr G. Roberts, Dr M. Vazquez-Ortiz and Dr P. Eigenmann (also editor-in-chief of the EAACI Paediatric Allergy and Immunology Journal).
If you are interested in participating, you can find more information through the link.
Look forward to seeing you there!
Best regards,
The Junior Member Assembly
